Literature DB >> 10694099

Predictive values of the ICT Tuberculosis test for the routine diagnosis of tuberculosis in Madagascar.

V Rasolofo1, T Rasolonavalona, H Ramarokoto, S Chanteau.   

Abstract

The rapid commercialised ICT Tuberculosis test has been tested in Madagascar for the diagnosis of smear-positive pulmonary (SM+) and extra-pulmonary tuberculosis (EPT), using microscopy, culture and histopathology as reference tests. Specificity was 83.3% and sensitivity 68.2% for SM+ patients and 65.2% for EPT patients. With a prevalence of 22.2% for SM+ patients and 52.4% for confirmed EPT among consulting patients in the National Reference Laboratory, the ICT Tuberculosis assay was not sufficiently predictive for application in the tuberculosis control programme.

Entities:  

Mesh:

Year:  2000        PMID: 10694099

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Poor performance of a novel serological test for diagnosis of pulmonary tuberculosis in Bangui, Central African Republic.

Authors:  Eric Kassa-Kelembho; Edith Kassa; Germain Zandanga; Yves-Brillant Service; Albert Ignaleamoko; Antoine Talarmin
Journal:  Clin Vaccine Immunol       Date:  2006-06

2.  Salivary sIg-A response against the recombinant Ag38 antigen of Mycobacterium tuberculosis Indonesian strain.

Authors:  Tri Yudani Mardining Raras; Gamal Sholeh; Diana Lyrawati
Journal:  Int J Clin Exp Med       Date:  2014-01-15

3.  Evaluation of an in-house-developed radioassay kit for antibody detection in cases of pulmonary tuberculosis and tuberculous meningitis.

Authors:  M Kameswaran; K Shetty; M K Ray; M A Jaleel; G V Kadival
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

4.  Evaluation of the ICT Tuberculosis test for the routine diagnosis of tuberculosis.

Authors:  Gozde Ongut; Dilara Ogunc; Filiz Gunseren; Candan Ogus; Levent Donmez; Dilek Colak; Meral Gultekin
Journal:  BMC Infect Dis       Date:  2006-02-27       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.